Q2 2024 · 13F-HR
Finepoint Capital LPholdings as filed
Filed 2024-08-13 · accession 0000904454-24-000458
$352.3M
Reported value
25
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 530307305 | LBRDK | LIBERTY BROADBAND CORP | $109.3M | 31.0% | 1,994,510 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $28.3M | 8.04% | 729,464 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $25.8M | 7.33% | 189,272 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $24.0M | 6.83% | 638,352 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $23.2M | 6.60% | 54,028 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $21.0M | 5.96% | 132,835 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $17.1M | 4.85% | 388,835 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $15.3M | 4.34% | 574,378 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $14.7M | 4.18% | 905,384 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $14.6M | 4.15% | 1,776,728 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $13.9M | 3.94% | 256,449 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $13.4M | 3.82% | 542,762 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $10.5M | 2.97% | 1,605,346 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $8.9M | 2.54% | 433,471 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $6.2M | 1.75% | 707,404 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $5.5M | 1.55% | 961,251 | Common | SOLE |
| 17144M110 | — | CHURCHILL CAPITAL CORP VII | $191,800 | 0.05% | 548,000 | Common | SOLE |
| G6202B119 | MNYWW | MONEYHERO LIMITED | $71,600 | 0.02% | 895,000 | Common | SOLE |
| 20607U116 | CNDAW | CONCORD ACQUISITION CORP II | $44,917 | 0.01% | 408,333 | Common | SOLE |
| G63836111 | IVCPW | SWIFTMERGE ACQUISITION CORP | $39,200 | 0.01% | 490,000 | Common | SOLE |
| G9845F117 | LSBWF | LAKESHORE BIOPHARMA CO LTD | $33,369 | 0.01% | 489,999 | Common | SOLE |
| 320703119 | CLDWW | CALIDI BIOTHERAPEUTICS INC | $27,584 | 0.01% | 655,200 | Common | SOLE |
| G2476C123 | CDAWF | COMPASS DIGITAL ACQUISITION CORP | $27,548 | 0.01% | 459,906 | Common | SOLE |
| 56608A113 | — | MARBLEGATE ACQUISITION CORP | $26,828 | 0.01% | 735,000 | Common | SOLE |
| 320703101 | — | CALIDI BIOTHERAPEUTICS INC | $25,000 | 0.01% | 125,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.